Zim Laboratories Limited Asset Resilience Ratio
Zim Laboratories Limited asset resilience ratio. Zim Laboratories Limited (ZIMLAB) has an Asset Resilience Ratio of 0.24% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See ZIMLAB defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Zim Laboratories Limited (2016–2025)
Asset resilience ratio of Zim Laboratories Limited from 2016 to 2025. This chart shows how Zim Laboratories Limited's Asset Resilience Ratio has changed over time. Read ZIMLAB current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Zim Laboratories Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Zim Laboratories Limited asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0% |
| Short-term Investments | Rs11.07 Million | 0.24% |
| Total Liquid Assets | Rs11.07 Million | 0.24% |
Asset Resilience Insights
- Limited Liquidity: Zim Laboratories Limited maintains only 0.24% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zim Laboratories Limited Industry Peers by Asset Resilience Ratio
Compare Zim Laboratories Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Tibet Rhodiola Pharmaceutical Holding Co
SHG:600211 |
Drug Manufacturers - Specialty & Generic | 11.84% |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091 |
Drug Manufacturers - Specialty & Generic | 26.36% |
|
Renhe Pharmacy Co Ltd
SHE:000650 |
Drug Manufacturers - Specialty & Generic | 37.54% |
|
Bide Pharmatech Co. Ltd. A
SHG:688073 |
Drug Manufacturers - Specialty & Generic | 9.46% |
|
Jianmin Pharmaceutical Group Co Ltd
SHG:600976 |
Drug Manufacturers - Specialty & Generic | 20.61% |
|
Qianjiang Yongan Pharmaceutical Co Ltd
SHE:002365 |
Drug Manufacturers - Specialty & Generic | 30.38% |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078 |
Drug Manufacturers - Specialty & Generic | 0.42% |
Zim Laboratories Limited Asset Resilience Ratio by Year (2016–2025)
Zim Laboratories Limited asset resilience ratio by year from 2016 to 2025. The table below shows the annual Asset Resilience Ratio data for Zim Laboratories Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 0.02% | Rs900.00K ≈ $9.73K |
Rs4.72 Billion ≈ $51.05 Million |
+0.01pp |
| 2024-03-31 | 0.01% | Rs403.00K ≈ $4.36K |
Rs4.47 Billion ≈ $48.32 Million |
0.00pp |
| 2023-03-31 | 0.01% | Rs453.00K ≈ $4.90K |
Rs3.42 Billion ≈ $36.94 Million |
-0.37pp |
| 2022-03-31 | 0.38% | Rs12.95 Million ≈ $140.00K |
Rs3.42 Billion ≈ $36.95 Million |
-4.78pp |
| 2021-03-31 | 5.16% | Rs167.65 Million ≈ $1.81 Million |
Rs3.25 Billion ≈ $35.12 Million |
+4.64pp |
| 2020-03-31 | 0.53% | Rs17.09 Million ≈ $184.85K |
Rs3.25 Billion ≈ $35.18 Million |
+2.39pp |
| 2019-03-31 | -1.86% | Rs-61.18 Million ≈ $-661.66K |
Rs3.28 Billion ≈ $35.52 Million |
-0.61pp |
| 2018-03-31 | -1.25% | Rs-37.34 Million ≈ $-403.83K |
Rs2.98 Billion ≈ $32.26 Million |
-1.25pp |
| 2017-03-31 | 0.00% | Rs1.00K ≈ $10.81 |
Rs2.59 Billion ≈ $28.02 Million |
+0.18pp |
| 2016-03-31 | -0.18% | Rs-4.56 Million ≈ $-49.36K |
Rs2.56 Billion ≈ $27.70 Million |
-- |
About Zim Laboratories Limited
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, granules, tablets, capsules, dry syrup, and oral thin films. The company offers the… Read more